Safety Alert for HEMODIALYSIS MACHINE DBB-06, Registration no. 80145240398, serial number: all series produced before September 2012, with the exception of the series 73030-5. See numbers of affected series in the annex .. http://portal.anvisa.gov.br/wps/wcm/connect/7d89b7804e316945950ab7c09d49251b/Number+of+Series+Afetados.pdf?MOD=AJPERES

According to Agência Nacional de Vigilância Sanitária (ANVISA), this safety alert involved a device in Brazil that was produced by Baxter Hospitalar Ltda.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event ID
    1221
  • Date
    2013-01-15
  • Event Country
  • Event Source
    ANVISA
  • Event Source URL
  • Notes / Alerts
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Extra notes in the data
    Although no adverse event is reported, the company reports that DBB-06 hemodialysis equipment may have additional risks for patients with CVC and undergo hemodialysis treatment. According to IEC 60601-2-16 currently harmonized in Brazil, patient leakage current in DBB-06 devices is classified as "type B" (lesser degree of requirement for permissible leakage current), but the new IEC 60601-2-16 (4th Edition) defines that hemodialysis equipment, when in use by patients with CVCs, must comply with the "CF type" patient leakage current limits (higher degree of the permissible leakage current). The corrective action will be performed to meet the requirements of the 4th Edition of the IEC 60601-2-16 standard not yet harmonized in Brazil. #### UPDATED ON 08/18/2017, the field action documentations submitted by the company are filed in the area. If necessary, the area can reassess the action at any time.
  • Reason
    Excessive leakage current in patients when in therapy using dbb-6 equipment in combination with a central venous catheter (cvc).
  • Action
    The company requests the kindness to take the following actions: i. Consider that DBB-6 Hemodialysis Equipment may have additional risks for patients using CVC. Therefore, avoid the treatment of patients in critical condition or with known coronary disease. It recommends using other hemodialysis equipment available on your service for these patients until the update is done. NOTE: This does not affect the treatment of patients who undergo hemodialysis treatment and use fistula access. ii. Fill out the Customer Response form, confirming receipt of the letter and sending it by e-mail to faleconosco@baxter.com or by fax at (0XX 11) 5694-8827. The immediate return of the form will prevent the warning from being sent repeatedly. It is NOT necessary to return Nikkiso's "Security Alert Receipt Confirmation", only Baxter's. Baxter Hospitalar will initiate corrective action to be performed by field service engineers during annual preventive maintenance by updating DBB-06 equipment to conform to the "CF Type" rating for patient leakage current.

Manufacturer

  • Source
    ANVSANVISA